Best Biopharma Outsourcing Companies in Bengaluru, India
The 115 best Biopharma Outsourcing companies in Bengaluru, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: SeQuent.
Our analysis of 50 Biopharma Outsourcing companies
$3.9b in tracked funding; 60% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2021.
Ranked: Best Biopharma Outsourcing companies in Bengaluru
| # | Company | Revenue | Disclosed funding | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Laurus Bio CDMO focused on providing services for stem cell, biological drugs, and regenerative medicines | $778M FY2026 | — | — | Rajesh Krishnamurthy Chief Executive Officer | WordPressMySQLPHP+30 | Top 5M | — | — |
| 2 | Syngene Provider of contract research and manufacturing services for both small molecules and biologics 78Tech top 20%Product top 22%Market top 23%Fin. health top 27% All 12 signals ▾Techtop 20% Producttop 22% Markettop 23% Fin. healthtop 27% Moattop 27% Fundingtop 28% Newstop 35% Talenttop 38% Patentstop 45% Innovationtop 47% Growthtop 48% Globalbottom 42% Tech: 83 technologies across 6/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 Product: 2 published apps (5.0k installs) · Company stage: Public rank vs industry peers · Fliar Intelligence Index 78/100 | $439M FY2025 | $86M | 5,482 5,482 → 7,926 (+45%) · sector median +23% | Jonathan Hunt CEO | WordPressMySQLPHP+40 | Top 1M | 8 patents Therapeutic small‑molecule discovery: menin‑MLL PPI inhibitors, kinase inhibitors, LPA antagonists. | — |
| 3 | Medreich Provider of pharmaceutical contract manufacturing and development services | $229M FY2025 | $25M | 1,207 | Pankaj Garg CEO & MD | BootstrapGoogle Font APIFont Awesome+9 | Top 5M | 13 patents Stable oral dosage forms for enzymes, glucosamine, ariprazole, and chewable mucolytic capsules | — |
| 4 | Anthem Biosciences Developer of integrated contract research development and manufacturing services 78Talent top 22%News top 23%Fin. health top 23%Moat top 25% All 11 signals ▾Talenttop 22% Newstop 23% Fin. healthtop 23% Moattop 25% Markettop 27% Patentstop 29% Fundingtop 38% Growthtop 38% Innovationtop 39% Techbottom 49% Globalbottom 42% Talent: Analyst team rating 5/5 · 3 named leaders on record News: 39 BI events in 12 mo (of 50 tracked, 5 types) · +457% YoY rank vs industry peers · Fliar Intelligence Index 78/100 | $228M FY2025 | $36M | 2,064 2,064 → 2,423 (+17%) · sector median +23% | Ravindra C Co-Founder & COO | WordPressMySQLPHP+17 | Top 5M | 47 patents Synthesis of glycolipid acids, peptide therapeutics, and small‑molecule guanylate cyclase agonists | 1 job opening · 2 awards |
| 5 | OneSource Pharmaceutical contract development and manufacturing organization offering pharmaceutical products 89Growth top 16%Moat top 18%Fin. health top 25%Funding top 27% All 8 signals ▾Growthtop 16% Moattop 18% Fin. healthtop 25% Fundingtop 27% Markettop 30% Techtop 46% Talentbottom 49% Globalbottom 45% Growth: Revenue +730% YoY Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · 9 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 89/100 | $173M FY2025 | $155M | — | Neeraj Sharma CEO & Managing Director | WordPressMySQLPHP+21 | Top 5M | — | — |
| 6 | Stelis Biosource CDMO providing solutions for end-to-end biopharmaceutical manufacturing needs 82Growth top 23%Fin. health top 26%Market top 28%Funding top 32% All 7 signals ▾Growthtop 23% Fin. healthtop 26% Markettop 28% Fundingtop 32% Moattop 34% Talentbottom 49% Globalbottom 37% Growth: Headcount 996 → 1,116 (+12%) across vintages · Revenue +730% YoY Fin. health: Revenue ~$173M (FY2022) · Net margin 1.5% rank vs industry peers · Fliar Intelligence Index 82/100 | $173M FY2025 | $195M | 1,116 | Arun Kumar Founder & Director | — | — | — | — |
| 7 | Aurigene Pharmaceutical Provider of drug development, formulation, and regulatory services for biopharma sector | $76M FY2025 | — | 902 902 → 1,150 (+27%) · sector median +23% | Akhil Ravi Chief Executive Officer | TypeScriptBootstrapZone.js+20 | Top 5M | — | 1 launch |
| 8 | R L Fine Chem Pharmaceutical company engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) | $43M FY2025 | $10M | 375 | Anjan Roy Founder | WordPressMySQLPHP+29 | Top 5M | 16 patents Synthesis of piperazine-based analgesic intermediates and bromine‑free polycyclic ketones | 1 job opening |
| 9 | Bioplus Life Sciences Provider of manufacturing & supplier of APIs, packaging, and drug formulation development services | $34M FY2025 | — | 303 | Sundeep Aurora Founder & CEO | — | — | 16 patents Lipid-based drug delivery formulations, especially omega‑fatty‑acid emulsions and sustained‑release systems. | — |
| 10 | Adgyl Lifesciences Provider of contract research, development, and manufacturing services for pharmaceutical preclinical testing… | $32M FY2025 | — | 259 | Haladasappa Krishnappa Managing Director | WordPress Block EditorWordPressMySQL+21 | Top 10M | — | — |
| 11 | Kemwell Biopharma A biologics CDMO providing integrated development and manufacturing | $28M FY2025 | $6M | 297 297 → 545 (+84%) · sector median +23% | Anurag Bagaria CEO & MD | WordPressMySQLPHP+26 | Top 5M | — | — |
| 12 | Arcolab Customer-centric outsourcing firm offers specialized services in the life sciences industry | $19M FY2025 | — | 421 421 → 468 (+11%) · sector median +23% | Arun Kumar Founder & Co-CEO & Managing Director | Node.jsTailwind CSSReact+12 | Top 5M | — | 1 partnership |
| 13 | Bioneeds Pre-Clinical CRO providing regulatory testing services | $15M FY2025 | $4M | 492 | — | WordPressMySQLPHP+20 | Top 10M | — | — |
| 14 | Beloorbayir Managed company engaged in the manufacturing and marketing of select active pharmaceutical ingredients and… | $9M FY2021 | $15M | 106 | Ganapayya Bairy Chairman & MD | BootstrapApache HTTP ServerPhotoSwipe+5 | Top 50M | — | — |
| 15 | BioQuest Provider of medical affairs consulting services for life science companies | $8M FY2025 | $761K | 283 283 → 338 (+19%) · sector median +23% | Rajesh Prabhakaran Co-Founder | WordPressMySQLPHP+23 | Top 5M | — | — |
| 16 | D Cube Analytics Analytics Platform for Pharmaceutical Brand Management | $3M FY2024 | — | 3 | — | — | — | — | — |
| 17 | ComBiotech Provider of custom chemical synthesis, process development, and manufacturing services | $3M FY2025 | — | — | Mohanaa O Founder & CEO | — | — | — | — |
| 18 | Vipragen Provider of drug discovery and development services 29Talent top 38%Fin. health top 43%Growth top 47%Tech bottom 44% All 8 signals ▾Talenttop 38% Fin. healthtop 43% Growthtop 47% Techbottom 44% Moatbottom 40% Fundingbottom 36% Globalbottom 32% Marketbottom 28% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Fin. health: Revenue ~$2.2M (FY2023) · Net margin 23.6% rank vs industry peers · Fliar Intelligence Index 29/100 | $2M FY2025 | $1M | 65 65 → 96 (+48%) · sector median +23% | Chandrashekaran Siddamadappa Co-Founder & Managing Director | BootstrapNginxIsotope+7 | Top 10M | — | 2 awards |
| 19 | ArkGen Pharma Research-based pharmaceutical company that manufactures APIs and intermediates for the health industry | $2M FY2025 | — | — | — | — | — | — | — |
| 20 | Biofern Life Sciences CDMO focused on manufacturing pharmaceutical formulations and marketing services | $2M FY2025 | — | — | Kolathur Srinarayanan Founder & CEO | WordPressMySQLPHP+13 | Top 10M | — | — |
| 21 | Bentley Nutraceuticals Provider of end-to-end contract manufacturing for nutraceutical, health supplement products | $2M FY2025 | — | 68 | Vasanth Ranka Founder | Cart FunctionalityWixSentry+13 | Top 50M | — | — |
| 22 | BioOrganics Offering integrated chemistry services for APIs and specialty chemicals | $1M FY2025 | — | 31 | Vijaykumar Hulikal Founder & Managing Director | Google MapsUbuntuBootstrap+11 | Top 10M | — | — |
| 23 | Agati Clinical Provider of clinical data services | $818K FY2021 | — | 144 144 → 119 (-17%) · sector median +23% | Ramanan Bathala Founder & CEO | WixSentryBootstrap+10 | Top 50M | — | — |
| 24 | Aristogene Biosciences Contract research and manufacturing organization offering enzymes and proteins | $692K FY2025 | — | 9 | Ruskin D Owner | YouTubeBootstrapNginx+6 | Top 50M | — | — |
| 25 | Axodin Pharma Manufacturer of generic finished formulations and APIs | $558K FY2025 | — | — | Rahul Saini CEO | WordPress Block EditorElementorWordPress+32 | Top 50M | — | — |
| 26 | Bio Agile Therapeutics Provider of real estate brokerage and related services | $324K FY2025 | — | — | Divya Chandradhara CEO | WordPress Block EditorElementorWordPress+13 | Top 10M | — | — |
| 27 | Stelis Biopharma Biosimilars and new drugs for range of diseases using mammalian and microbial cell lines 21Funding top 36%Growth top 45%Moat bottom 45%Talent bottom 45% All 10 signals ▾Fundingtop 36% Growthtop 45% Moatbottom 45% Talentbottom 45% Marketbottom 41% Newsbottom 36% Globalbottom 36% Patentsbottom 33% Innovationbottom 21% Fin. healthbottom 10% Funding: Raised $200M · 4 rounds over 11 yrs (0.4/yr) Growth: Headcount 996 → 1,116 (+12%) across vintages rank vs industry peers · Fliar Intelligence Index 21/100 | $324K FY2020 | $200M | 1,116 | Sohang Chatterjee Co-Founder | — | — | 6 patents Purification of recombinant proteins and engineered insulin analog manufacturing. | — |
| 28 | Anax Pharma Manufacturer of tablets, syrup, and injectables | $264K FY2025 | — | — | — | — | — | — | — |
Top 12 Biopharma Outsourcing companies in Bengaluru
#1
Public · Bengaluru, Karnataka · founded 1993 · 5482 employees$85.9Mraised▾
Provider of contract research and manufacturing services for both small molecules and biologics. Its discovery services cover multiple domains across small molecules, large molecules, antibody-drug conjugates (ADC) and oligonucleotides. Its biological services include recombinant DNA engineering, cell line development, hybridoma technology, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. Its synthetic chemistry and medicinal chemistry services can be accessed with emphasis either on chemistry discipline capabilities or more comprehensively along with DMPK and biological support.
- Feb 2023Post IPO$131.2M
- Sep 2014PE$62.6M
- Oct 2012PE$23.2M
#2
Acquired · Bengaluru, Karnataka · founded 2002 · 750 employees$659.4Mraised▾
SeQuent is into developing and manufacturing of APIs for multiple therapeutic areas with three manufacturing facilities in Karnataka and Maharashtra. SeQuent Research Limited (SRL) is the research arm of Sequent offering contract research services specialized in Analytical and Bio Analytical Services to support the API, Pharmaceutical, Personal Care and Nutraceutical companies
- Jun 2020Post IPO—
- May 2015Post IPO$627.8M
- Apr 2014Post IPO$31.5M
#3
Public · Bengaluru, Karnataka · founded 1990$155.5Mraised▾
OneSource is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in biologics, drug-device combinations, soft gelatin capsules, and sterile injectables. With expertise across multiple therapeutic modalities, OneSource offers end-to-end capabilities for pharmaceutical companies. The company's broad capabilities enable it to support clients throughout the product development lifecycle, from development to commercialization.
- Mar 2021Series C$80M
- Nov 2018Series B$42.9M
- Feb 2016Series B$31.2M
- Jul 2010Angel$167.3K
#4
Series C · Bengaluru, Karnataka · founded 2012 · 1116 employees$195Mraised▾
Stelis BioSource is the CDMO arm of Stelis Biopharma, providing solutions for end-to-end biopharmaceutical manufacturing needs. It offers services such as process development & scale- up, analytical development and cGMP manufacturing. The process development services include upstream development & scale up services in both microbial & mammalian expression systems, downstream processes such as chromatography, filtration, precipitation/crystallization, virus removal & inactivation and formulation development such as injectable in vials, prefilled syringes & cartridges. It offers analytical services such as bioassay development, product characterization & stability testing. It has cGMP certified manufacturing facilities.
- Mar 2021Series C$125M
- Series B$70M
#5
Acquired · Bengaluru, Karnataka · founded 2007 · 1116 employees$200.4Mraised▾
Operator of a healthcare company intended to serve patients in both emerging and developed markets. The company develops, manufactures, and commercializes products targeted against large treatment markets and includes products like differentiated biosimilars, novel biologics, and other complex large molecules, enabling patients with treatments at an affordable cost.
#6
Series A · Bengaluru, Karnataka · founded 2012 · 65 employees$1.5Mraised▾
Provider of drug discovery and development services. Its proficiency with these tests helps to ensure the safety and effectiveness of possible pharmaceutical compounds during the development process by thoroughly evaluating and advancing them. It offers excellent and reasonably priced discovery chemistry services that span the whole range from target validation to clinical candidature and include thorough molecular modelling support.
- Aug 2023Series A$421.7K
- May 2019Seed$657.9K
- May 2018Seed$343.6K
- Jan 2018Seed$269.1K
#7
Public · Bengaluru, Karnataka · founded 2006 · 2064 employees$35.7Mraised▾
Developer of integrated contract research development and manufacturing services. The company offers end‑to‑end drug discovery, development and manufacturing support for small molecules, biologics and nutritional actives. It provides medicinal chemistry, process synthesis, analytical R&D, toxicology and GLP preclinical testing under one roof. Services include microbial screening, protein expression, peptide synthesis, antibody drug conjugates and fermentation scale‑up capable from milligram to tonne volumes. The infrastructure includes cGMP kilo‑labs, pilot manufacturing and AAALAC accredited vivarium for in vitro and in vivo studies. Quality control, regulatory compliance and analytical method development are embedded as part of the scientific service portfolio.
- Mar 2021Series A$33.4M
- Nov 2016Seed$1.8M
- 2012Grant (prize money)—
- May 2008Seed$577.4K
#8
Acquired · Bengaluru, Karnataka · founded 1976 · 1207 employees$25Mraised▾
Provider of pharmaceutical contract manufacturing and development services. This includes formulation development, analytical services, clinical and commercial manufacturing, and packaging design. The company offers services across various dosage forms and therapeutic categories, supporting clients from proof of concept through to final product. A focus is on developing formulations as patent non-infringing and niche generics for global markets. Services also encompass pharmacovigilance.
#9
Early Stage · Bengaluru, Karnataka · founded 1981 · 106 employees$14.7Mraised▾
Managed company engaged in the manufacturing and marketing of select active pharmaceutical ingredients and nutraceuticals. It offers a broad portfolio of APIs and focuses on natural and nature-similar medicines, including botanical extracts sourced from wild and cultivated pesticide-free plants. The company has a strong emphasis on research and development, with a DSIR-recognized R&D lab working on therapeutic areas such as neuroscience, pain management, anti-infectives, vital organ functioning, and cardiovascular diseases.
- Oct 2016Unattributed$2.5M
- Mar 2014Unattributed$12.3M
#10
Acquired · Bengaluru, Karnataka · founded 2006 · 492 employees$3.7Mraised▾
Bioneeds is a GLP-certified pre-clinical CRO offering regulatory testing services for Pharmaceutical (GLP toxicology studies including Acute studies, Repeat-dose studies and Genotoxicity), Biopharmaceuticals (GLP Toxicology studies, Immunogenicity and PK assays), Agrochemicals (LP toxicology studies, Eco-toxicology studies, Phys-Chem analysis and Packaging Solutions), Industrial Chemicals, Medical Devices (Cytoxicity and Genotoxicity, Systemic Toxicity, Sensitzation and Irritation, Hemo-compatibility and Implantation testing), Herbals and Nutraceuticals .
- Mar 2021Series A—
- Dec 2015Series A$3.7M
#11
Series A · Bengaluru, Karnataka · founded 2011 · 375 employees$10.4Mraised▾
R L Fine Chem is engaged in manufacturing of active pharmaceutical ingredients. The company claims to specialize in CNS drugs, cardiovascular drugs, antihistamine drugs and muscle relaxant drugs. It has a portfolio of 19 API products combined with its sister concern company Ray chemicals. Services offered include CRAMS, impurities and reference standard, stability trial samples for oral dosage form, analytical method development and validation and pre-formulation studies. Internationally, it has a presence in countries like USA, Canada, Europe, Latin America, Japan, South East Asia, Bangladesh and the Far East etc. Certifications include FDA, PMDA, COFEPRIS, WHO-GMP, ISO, OHSAS 18001, and EDQM.
- Aug 2016Series A$10.4M
#12
Series A · Bengaluru, Karnataka · founded 2011 · 1 employees$4.7Mraised▾
Cytespace Research offers a range of site-related services to bio-pharmaceutical sponsors and CROs. They partner with networks of hospitals, doctors, and patients, create scalable technology platforms to access clinical research sites and patient networks in emerging markets, and deploy best-in-class clinical research site solutions for the conduct of efficient, predictable, auditable and ethical clinical trials. They offer trial solutions such as feasibility studies, regulatory services, supply chain solutions, and site solutions such as site start-up, trial management, patient recruitment and retention.
- May 2013Series A$1.5M
- Oct 2012Series A$1.6M
- May 2012Seed$550.9K
- Sep 2011Seed$1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time falling
Funding & growth over time
funding flat · growth rising
How research on Biotechnology in Bengaluru is moving
A read on the academic research around Biotechnology in Bengaluru — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 72 papers.
University of Agricultural Sciences and IISc Bangalore lead research on silkworm sericulture, silk biomaterials, and DNA repair, with a cautiously optimistic tone (mean stance 0.48).
- University of Agricultural Sciences, Bangalore24
- Indian Institute of Science Bangalore16
- Bangalore University8
- Indian Institute of Science Education and Research Pune6
- Indian Institute of Science Education and Research Thiruvananthapuram5
- Gene3
- Agriculture2
- Genome2
- Plasmid2
- DNA ligase1
- Antimicrobial8
- Agriculture3
- Yield (engineering)3
- Antimicrobial peptides3
- Immune system3
- Pathosystem1
- Phosphate1
- Effector1
- Oryza sativa1
- Plant disease resistance1
Who's building biotechnology IP in Bengaluru
Biocon dominates Bengaluru's biotechnology patent activity with 689 of 956 total patents, while annual filings have trended downward since 2021's peak of 61.
- Biocon689Bengaluru
- Avesthagen87Bengaluru
- String Bio42Bengaluru
- Anthem Biosciences25Bengaluru
- National Centre for Biological Sciences19Bangalore
- GangaGen13Bengaluru
- sami-sabinsa group13Bangalore
- Mynvax9Bengaluru
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.